Analyst Ratings for Amylyx Pharmaceuticals inc. (AMLX)
AMLX Rating Summary
AMLX Price Target Summary
- Highest: $57.00 (Guggenheim)
- Lowest: $22.00 (BofA Securities)
- Average: $45.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$45.50 (+56.7%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
Avg. $ Target:
$45.50 (+56.7%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2026 | Stifel » Updated 10/1/2026 |
James Condulis | New Coverage | Buy (N/A) |
45.00 (N/A) |
15.17 (29.03) |
91.36% | Details |
| 7/10/2025 | Goldman Sachs » Updated 8/27/2025 |
Corinne Johnson | New Coverage | Buy (N/A) |
10.00 (N/A) |
6.98 (29.03) |
315.9% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
